Anthony Scott Praill - Net Worth and Insider Trading

Anthony Scott Praill Net Worth

The estimated net worth of Anthony Scott Praill is at least $98 dollars as of 2024-05-15. Anthony Scott Praill is the CFO of Kintara Therapeutics Inc and owns about 744 shares of Kintara Therapeutics Inc (KTRA) stock worth over $98. Details can be seen in Anthony Scott Praill's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anthony Scott Praill has not made any transactions after 2021-12-08 and currently still holds the listed stock(s).

Transaction Summary of Anthony Scott Praill

To

Anthony Scott Praill Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony Scott Praill owns 1 companies in total, including Kintara Therapeutics Inc (KTRA) .

Click here to see the complete history of Anthony Scott Praill’s form 4 insider trades.

Insider Ownership Summary of Anthony Scott Praill

Ticker Comapny Transaction Date Type of Owner
KTRA Kintara Therapeutics Inc 2021-12-08 Chief Financial Officer

Anthony Scott Praill Latest Holdings Summary

Anthony Scott Praill currently owns a total of 1 stock. Anthony Scott Praill owns 744 shares of Kintara Therapeutics Inc (KTRA) as of December 8, 2021, with a value of $98.

Latest Holdings of Anthony Scott Praill

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KTRA Kintara Therapeutics Inc 2021-12-08 744 0.13 98

Holding Weightings of Anthony Scott Praill


Anthony Scott Praill Form 4 Trading Tracker

According to the SEC Form 4 filings, Anthony Scott Praill has made a total of 1 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 574 shares on December 8, 2021, which cost Anthony Scott Praill around $19,516.

Insider Trading History of Anthony Scott Praill

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anthony Scott Praill Trading Performance

GuruFocus tracks the stock performance after each of Anthony Scott Praill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Scott Praill is -15.25%. GuruFocus also compares Anthony Scott Praill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Scott Praill within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anthony Scott Praill's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anthony Scott Praill

Average Return

Average return per transaction

Outperforming Transactions

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.5
Relative Return to S&P 500(%) -6.91

Anthony Scott Praill Ownership Network

Ownership Network List of Anthony Scott Praill

No Data

Ownership Network Relation of Anthony Scott Praill


Anthony Scott Praill Owned Company Details

What does Kintara Therapeutics Inc do?

Who are the key executives at Kintara Therapeutics Inc?

Anthony Scott Praill is the Chief Financial Officer of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , director & Head of Strategic Partnerships Saiid Zarrabian , and Chief Scientific Officer Dennis M Brown .

Kintara Therapeutics Inc (KTRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kintara Therapeutics Inc Insider Transactions

No Available Data

Anthony Scott Praill Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony Scott Praill. You might contact Anthony Scott Praill via mailing address: 2001-889 Homer Street, Vancouver A1 V6b 5s3.

Discussions on Anthony Scott Praill

No discussions yet.